Affiliation:
1. Department of Metabolism and Diabetes, Centre of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Abstract
Metformin is widely used in the treatment of Type 2 diabetes, however, mechanisms of its antihyperglycemic effect were not yet fully elucidated. Complex I of mitochondrial respiration chain is considered as one of the possible targets of metformin action. In this paper, we present data indicating that the inhibitory effect of metformin can be tested also in liver homogenate. Contrary to previous findings on hepatocytes or mitochondria under our experimental conditions, lower metformin concentrations and shorter time of preincubation give significant inhibitory effects. These conditions enable to study the mechanism of the inhibitory effect of metformin in small samples of biological material (50-100 mg wet weight) and compare more experimental groups of animals because isolation of mitochonria is unnecessary.
Publisher
Institute of Physiology of the Czech Academy of Sciences
Subject
General Medicine,Physiology
Reference15 articles.
1. BAILEY CJ, TURNER RC: Metformin. New Engl J Med 334: 574-579, 1996.
2. BRADFORD MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
3. CAHOVÁ M, DRAHOTA Z, OLIVARNYK O, KUČERA O, DANKOVÁ H, KAZDOVÁ L: The effect of metformin on liver mitochondria and lipid metabolism in NAFLD. Diabetologia 53 (Suppl 1): S304, 2010.
4. CARVALHO C, CORREIA S, SANTOS MS, SELCA R, OLIVEIRA CR, MOREIRA PI: Metformin promotes isolated rat liver mitochondrial impairment. Mol Cell Bioch 308: 75-83, 2008.
5. ČERVINKOVÁ Z, RAUCHOVÁ H, KŘIVÁKOVÁ P, DRAHOTA Z: Inhibition of palmityl carnitine oxidation in rat liver mitochondria by tert-butyl hydroperoxide. Physiol Res 57: 133-136, 2008.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献